Paper41357129
Scavenging of reactive oxygen and nitrogen species using nanoparticles and their applications in disease management.
Rananaware P and 2 others. RSC Adv, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Scavenging of reactive oxygen and nitrogen species using nanoparticles and their applications in disease management. Papers, record 41357129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41357129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Scavenging of reactive oxygen and nitrogen species using nanoparticles and their applications in disease management.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30540450 | Chiral Molecule-mediated Porous Cu xO Nanoparticle Clusters with Antioxidation Activity for Ameliorating Parkinson's Disease. | J Am Chem Soc | 2019 | https://conductscience.org/library/papers/30540450 | PubMed |
| 2 | 18544350 | Thiol chemistry and specificity in redox signaling. | Free Radic Biol Med | 2008 | https://conductscience.org/library/papers/18544350 | PubMed |
| 3 | 29731617 | Oxidative stress, aging, and diseases. | Clin Interv Aging | 2018 | https://conductscience.org/library/papers/29731617 | PubMed |
| 4 | 29449774 | Reactive Oxygen Species: A Key Constituent in Cancer Survival. | Biomark Insights | 2018 | https://conductscience.org/library/papers/29449774 | PubMed |
| 5 | 31244237 | Carbogenic Nanozyme with Ultrahigh Reactive Nitrogen Species Selectivity for Traumatic Brain Injury. | Nano Lett | 2019 | https://conductscience.org/library/papers/31244237 | PubMed |
| 6 | 15134560 | Oxygen, reactive oxygen species and tissue damage. | Curr Pharm Des | 2004 | https://conductscience.org/library/papers/15134560 | PubMed |
| 7 | 27940194 | Endocytosis of cerium oxide nanoparticles and modulation of reactive oxygen species in human ovarian and colon cancer cells. | Acta Biomater | 2017 | https://conductscience.org/library/papers/27940194 | PubMed |
| 8 | 32151012 | Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32151012 | PubMed |
| 9 | 11976187 | Aging and the role of reactive nitrogen species. | Ann N Y Acad Sci | 2002 | https://conductscience.org/library/papers/11976187 | PubMed |
| 10 | 23936755 | Cerium oxide nanoparticles accelerate the decay of peroxynitrite (ONOO(-)). | Drug Deliv Transl Res | 2013 | https://conductscience.org/library/papers/23936755 | PubMed |
| 11 | 33210670 | A ROS-scavenging multifunctional nanoparticle for combinational therapy of diabetic nephropathy. | Nanoscale | 2020 | https://conductscience.org/library/papers/33210670 | PubMed |
| 12 | 27997170 | Comprehensive Insights into the Multi-Antioxidative Mechanisms of Melanin Nanoparticles and Their Application To Protect Brain from Injury in Ischemic Stroke. | J Am Chem Soc | 2017 | https://conductscience.org/library/papers/27997170 | PubMed |
| 13 | 28643857 | Ceria-Zirconia Nanoparticles as an Enhanced Multi-Antioxidant for Sepsis Treatment. | Angew Chem Int Ed Engl | 2017 | https://conductscience.org/library/papers/28643857 | PubMed |
| 14 | 38149175 | ROS-scavenging materials for skin wound healing: advancements and applications. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/38149175 | PubMed |
| 15 | 22903797 | Reactive oxygen species: from health to disease. | Swiss Med Wkly | 2012 | https://conductscience.org/library/papers/22903797 | PubMed |
| 16 | 12656637 | Peroxynitrate and peroxynitrite: a complete basis set investigation of similarities and differences between these NOx species. | J Am Chem Soc | 2003 | https://conductscience.org/library/papers/12656637 | PubMed |
| 17 | 31244927 | Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease. | Theranostics | 2019 | https://conductscience.org/library/papers/31244927 | PubMed |
| 18 | 26388766 | Age-related neurodegenerative disease research needs aging models. | Front Aging Neurosci | 2015 | https://conductscience.org/library/papers/26388766 | PubMed |
| 19 | 23382918 | Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer. | PLoS One | 2013 | https://conductscience.org/library/papers/23382918 | PubMed |
| 20 | 29051850 | Functional Recovery of Contused Spinal Cord in Rat with the Injection of Optimal-Dosed Cerium Oxide Nanoparticles. | Adv Sci (Weinh) | 2017 | https://conductscience.org/library/papers/29051850 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41641235 | Multifunctional Se-Cu bimetallic nanoparticles from marine Bacillus licheniformis: targeting oxidative stress, inflammation, and microbial biofilms. | RSC Adv | 2026 | https://conductscience.org/library/papers/41641235 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41357129
GET https://conductscience.org/api/papers/v1/41357129/references?page=2